ResearcherUniversity of MacauActive in the last 2 years

Hang Fai Kwok

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-6349-4517; OpenAlex author ID A5056801628.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

An AI-derived peptide PCa2 suppresses pancreatic cancer growth via modulation of the ErbB/PI3K/AKT/mTOR/MYC signaling axis. Last author DOI 10.1186/s12964-026-02856-6 ↗
Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo. Last author DOI 10.1016/j.ejps.2017.05.057 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Weimin Zuo · 1 shared paper, 2026
- Paper An AI-derived peptide PCa2 suppresses pancreatic cancer growth via modulation of the ErbB/PI3K/AKT/mTOR/MYC signaling a… DOI 10.1186/s12964-026-02856-6 ↗
Ruiyu Xie · 1 shared paper, 2017
- Paper Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo. DOI 10.1016/j.ejps.2017.05.057 ↗
Jie Ye · 1 shared paper, 2017
- Paper Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo. DOI 10.1016/j.ejps.2017.05.057 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.